Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
基本信息
- 批准号:10604370
- 负责人:
- 金额:$ 397.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-15 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAbbreviationsAffectAfrican American populationAgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskArtificial IntelligenceAsian populationAwardBenchmarkingCalibrationCaregiversCaribbean HispanicCellsChIP-seqClinicalCognitiveCollectionCommunitiesComputer softwareCopy Number PolymorphismDataData AnalysesData CollectionData SetDiseaseDocumentationDrug TargetingElderlyEnvironmentEpigenetic ProcessEquilibriumEthnic PopulationEuropeanFosteringFrontotemporal DementiaFundingGenesGeneticGenetic AnnotationGenetic DiseasesGenomeGenomicsGoalsGrantHi-CIndividualInfrastructureInternationalLGR5 geneLewy Body DementiaMachine LearningMapsMethodsMethylationMolecular ConformationNational Heart, Lung, and Blood InstituteNational Human Genome Research InstituteNational Institute on AgingNot Hispanic or LatinoParkinson&aposs DementiaPathway interactionsPatientsPersonsPhasePrecision Medicine InitiativePredispositionPreventionProcessProgressive Supranuclear PalsyProteomicsPublic HealthQuality ControlResearchResearch PersonnelResourcesRisk FactorsSamplingScientistSequence AlignmentSingle Nucleotide PolymorphismSourceSystems AnalysisTrans-Omics for Precision MedicineUnited StatesVariantWorkcandidate identificationcognitive systemcollaborative environmentcomputer codecomputing resourcescorticobasal degenerationdata repositorydeep learningdeep neural networkdrug candidateexomeexome sequencingfile formatfunctional genomicsgene networkgenetic variantgenome analysisgenome wide association studygenome-wide linkagegenomic datainsertion/deletion mutationlearning networkmetabolomicsneural networknovel therapeutic interventionphenotypic datapreventprogramsquality assurancereference genometherapeutic candidatetherapeutic targettraittranscriptome sequencingwhole genome
项目摘要
Overall Project Summary
Alzheimer’s disease (AD) affects 5.8 million people in the United States, and is an immense
burden on patients, caregivers and on the economy. No disease-modifying treatments or
preventions exist, and we need better understanding of the disease and new therapeutic
strategies. Genetic discoveries are one source of candidate therapeutic targets. One source of
genetic targets is the Alzheimer’s Disease Sequencing Project (ADSP), a National Institute on
Aging (NIA) initiative since 2012 to sequence genomes and exomes of AD subjects and
cognitively normal elderly controls.
The Genome Center for Alzheimer’s Disease (GCAD) is the analysis coordinating center for the
ADSP. In the previous grant cycle, GCAD processed all AD-relevant sequencing data producing
harmonized genetic data for AD research. This renewal responds to the increase in the amount
and complexity of ADSP sequence data, the collection of new types of data, and an expansion
of the types of analysis being performed. In addition to sequence data, GCAD will harmonize
functional genomics data. GCAD will provide fully quality-controlled and annotated genetic and
functional genomics data that is analysis ready. In addition to AD, GCAD will also work with
data for AD related disorders (ADRD). These include frontotemporal dementias (FTDs),
progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Lewy body dementia
(LBD), and Parkinson’s disease with dementia (PD-d).
In the Y6-10 funding period, GCAD will assemble and harmonize whole-genome/whole-exome
sequencing data, and provide it to ADSP investigators and the general scientific community.
GCAD will work with US and non-US groups to analyze data by fostering a collaborative
environment, and providing infrastructure support. GCAD will also assemble and harmonize
functional genomics data which will be integral to identifying genes as candidate drug targets.
The research plan will lead to a high quality, comprehensive, harmonized collection of genetic
and functional data with detailed supporting resources including documentation and optimized
computer codes. This resource will be invaluable for the entire AD research community.
总体项目摘要
阿尔茨海默氏病(AD)在美国影响580万人,这是一个巨大的
对患者,看护人和经济负担的负担。没有改良疾病的治疗或
存在预防,我们需要更好地了解该疾病和新疗法
策略。遗传发现是候选治疗靶点的来源。一个来源
遗传目标是阿尔茨海默氏病测序项目(ADSP),美国国家研究所
自2012年以来,衰老(NIA)倡议序列的AD受试者的基因组和外部
认知正常的较早对照。
阿尔茨海默氏病基因组中心(GCAD)是分析协调中心
adsp。在上一个赠款周期中,GCAD处理了所有与广告相关的测序数据生产
用于AD研究的统一遗传数据。这种更新对数量增加的响应
ADSP序列数据的复杂性,新类型数据的收集以及扩展
进行的分析类型。除序列数据外,GCAD还将和谐
功能基因组学数据。 GCAD将提供完全质量控制和注释的遗传和
已准备好分析的功能基因组数据。除了广告外,GCAD还将与
广告相关疾病的数据(ADRD)。这些包括额颞痴呆(FTD),
进行性上腹部麻痹(PSP),皮质型变性(CBD),Lewy身体痴呆症
(LBD)和患有痴呆症(PD-D)的帕金森氏病。
在Y6-10的资金期间,GCAD将组装和协调全基因组/全基因组
对数据进行测序,并将其提供给ADSP研究人员和一般科学界。
GCAD将与我们和非US组合作,通过促进协作来分析数据
环境,并提供基础设施支持。 GCAD还将组装和协调
功能基因组学数据将是将基因识别为候选药物靶标的不可或缺的一部分。
该研究计划将导致高质量,全面,统一的通用收集
以及具有详细支持资源的功能数据,包括文档和优化
计算机代码。该资源对于整个广告研究界将是无价的。
项目成果
期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Admixture mapping implicates 13q33.3 as ancestry-of-origin locus for Alzheimer disease in Hispanic and Latino populations.
- DOI:10.1016/j.xhgg.2023.100207
- 发表时间:2023-07-13
- 期刊:
- 影响因子:0
- 作者:Horimoto, Andrea R. V. R.;Boyken, Lisa A.;Blue, Elizabeth E.;Grinde, Kelsey E.;Nafikov, Rafael A.;Sohi, Harkirat K.;Nato, Alejandro Q.;Bis, Joshua C.;Brusco, Luis I.;Morelli, Laura;Ramirez, Alfredo;Dalmasso, Maria Carolina;Temple, Seth;Satizabal, Claudia;Browning, Sharon R.;Seshadri, Sudha;Wijsman, Ellen M.;Thornton, Timothy A.
- 通讯作者:Thornton, Timothy A.
SparkINFERNO: a scalable high-throughput pipeline for inferring molecular mechanisms of non-coding genetic variants.
SparkINFERNO:一个可扩展的高通量管道,用于推断非编码遗传变异的分子机制。
- DOI:10.1093/bioinformatics/btaa246
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Kuksa,PavelP;Lee,Chien-Yueh;Amlie-Wolf,Alexandre;Gangadharan,Prabhakaran;Mlynarski,ElizabethE;Chou,Yi-Fan;Lin,Han-Jen;Issen,Heather;Greenfest-Allen,Emily;Valladares,Otto;Leung,YukYee;Wang,Li-San
- 通讯作者:Wang,Li-San
Packaging Biocomputing Software to Maximize Distribution and Reuse.
打包生物计算软件以最大化分发和再利用。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Bush,WilliamS;Wheeler,Nicholas;Beaulieu-Jones,Brett;Darabos,Christian
- 通讯作者:Darabos,Christian
ODACH: a one-shot distributed algorithm for Cox model with heterogeneous multi-center data.
- DOI:10.1038/s41598-022-09069-0
- 发表时间:2022-04-22
- 期刊:
- 影响因子:4.6
- 作者:Luo, Chongliang;Duan, Rui;Naj, Adam C.;Kranzler, Henry R.;Bian, Jiang;Chen, Yong
- 通讯作者:Chen, Yong
FILER: a framework for harmonizing and querying large-scale functional genomics knowledge.
- DOI:10.1093/nargab/lqab123
- 发表时间:2022-03
- 期刊:
- 影响因子:4.6
- 作者:Kuksa PP;Leung YY;Gangadharan P;Katanic Z;Kleidermacher L;Amlie-Wolf A;Lee CY;Qu L;Greenfest-Allen E;Valladares O;Wang LS
- 通讯作者:Wang LS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERARD DAVID SCHELLENBERG其他文献
GERARD DAVID SCHELLENBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERARD DAVID SCHELLENBERG', 18)}}的其他基金
Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD)
阿尔茨海默病遗传学和基因组学协调中心 (CGAD)
- 批准号:
9472453 - 财政年份:2017
- 资助金额:
$ 397.33万 - 项目类别:
Coordinating Center for Genetics and Genomics of Alzheimer's Disease (CGAD)
阿尔茨海默病遗传学和基因组学协调中心 (CGAD)
- 批准号:
9892934 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别:
Project 1: Identifying genes and Pathways that impact Tau Toxicity in FTD
项目 1:识别影响 FTD 中 Tau 毒性的基因和途径
- 批准号:
10012956 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10388085 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10090891 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别:
3/3-Sequencing Autism Spectrum Disorder Extended Pedigrees
3/3 测序自闭症谱系障碍扩展谱系
- 批准号:
8659502 - 财政年份:2012
- 资助金额:
$ 397.33万 - 项目类别:
3/3-Sequencing Autism Spectrum Disorder Extended Pedigrees
3/3 测序自闭症谱系障碍扩展谱系
- 批准号:
8877310 - 财政年份:2012
- 资助金额:
$ 397.33万 - 项目类别:
相似海外基金
Renal Osteodystrophy Precision Medicine Project
肾性骨营养不良精准医疗项目
- 批准号:
10705266 - 财政年份:2022
- 资助金额:
$ 397.33万 - 项目类别:
Determing the genetic basis of responses to biomechanical strain in an in vitro model of osteoarthritis
确定骨关节炎体外模型中生物力学应变反应的遗传基础
- 批准号:
10156429 - 财政年份:2021
- 资助金额:
$ 397.33万 - 项目类别:
Determing the genetic basis of responses to biomechanical strain in an in vitro model of osteoarthritis
确定骨关节炎体外模型中生物力学应变反应的遗传基础
- 批准号:
10348171 - 财政年份:2021
- 资助金额:
$ 397.33万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10388085 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别:
Genome Center for Alzheimer's Disease (GCAD)
阿尔茨海默病基因组中心 (GCAD)
- 批准号:
10090891 - 财政年份:2016
- 资助金额:
$ 397.33万 - 项目类别: